Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure.
about
Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunitiesPotential role of dipeptidyl peptidase IV in the pathophysiology of heart failureThe multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic diseaseRelationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal WomenSoluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study.The skin landscape in diabetes mellitus. Focus on dermocosmetic management.Methylglyoxal-Induced Endothelial Cell Loss and Inflammation Contribute to the Development of Diabetic CardiomyopathyPathophysiology of diabetic erectile dysfunction: potential contribution of vasa nervorum and advanced glycation endproducts.Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease.Effect of diet-derived advanced glycation end products on inflammation.RAGE and glyoxalase in kidney disease.Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs.Abundance, localization, and functional correlates of the advanced glycation end-product carboxymethyl lysine in human myocardium.Cardiomyocyte mitochondrial respiration is reduced by receptor for advanced glycation end-product signaling in a ceramide-dependent manner.
P2860
Q26825697-EF003C6F-4107-47B6-B739-D54BE4FE2667Q26829634-7B10AF6D-B464-42E7-A0F3-3131B1FC119EQ28830568-429459A0-5506-4632-9BB8-C9B1B7B2E8E7Q36047141-4B2A7774-3FC6-4CE4-9DC9-6423C8751118Q36263332-7AAAAE60-F1F5-4C8A-A534-D04B3DEDF5B0Q36857213-0A007A7E-A618-4BAE-9DFC-40A442E9FACCQ36930808-785694B4-997D-4BAA-8764-B8F63166112BQ38036887-1A7576F4-9311-47FE-93C5-1459FC57F6A9Q38370045-3AFB2694-A56B-4E54-9899-9189BE25AB59Q38588208-BD0C6FA1-8564-4D83-9C8E-6A0ECF960152Q38857649-7B9BAF4F-F4B7-4C62-B734-D139B2CCD2ABQ38859313-41B099CB-A53C-4412-BFDD-F3EFDE7668D2Q39436295-F0796D74-9378-4D2F-9207-A9886725CCDFQ50078700-E4C5848B-6756-4BB7-A425-795245F6CFD4Q50587751-6EDC2512-5B68-4E63-AD9F-2BB16C8FE8A1
P2860
Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Receptor for advanced glycatio ...... hophysiology of heart failure.
@en
type
label
Receptor for advanced glycatio ...... hophysiology of heart failure.
@en
prefLabel
Receptor for advanced glycatio ...... hophysiology of heart failure.
@en
P2860
P1476
Receptor for advanced glycatio ...... hophysiology of heart failure.
@en
P2093
Ann Marie Schmidt
Ravichandran Ramasamy
P2860
P2888
P304
P356
10.1007/S11897-012-0089-5
P577
2012-06-01T00:00:00Z